Literature DB >> 3395272

Identification of Apo B-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans.

G Camejo1, S O Olofsson, F Lopez, P Carlsson, G Bondjers.   

Abstract

The interactions of low density lipoprotein (LDL) and apolipoprotein (apo) B-100 segments with chondroitin-6-SO4 rich aortic proteoglycans aggregate (CSPG) were studied by using quantitative frontal elution affinity chromatography. The affinity of the agarose-CSPG was higher for LDL than for very low density lipoprotein and high density lipoprotein was not bound. LDL from different individuals had dissociation coefficients (Kd) from 28 to 179 nM. Experiments with tryptic hydrolysates of apo B suggested that the capacity of LDL to bind with CSPG resides in the protein. Nine apo B-100 hydrophilic peptides, 12 to 26 amino acids long, were selected, and three were found to interact with the agarose-bound CSPG: apo B P-1 (LRKHKLIDVISMYRELLKDLSKEA, residues 4230 to 4254), apo B P-2 (RLTRKRGLKLATALSLSNK, residues 3359 to 3377), and apo B P-11 (RQVSHAKEKLTALTKK, residues 2106 to 2121). These peptides competed with LDL for binding to the agarose-bound and soluble CSPG; apo B P-2 was the most effective. This correlates with Kd values: 63, 86, and 82 microM for apo B P-2, P-1, and P-11, respectively. The peptides shared an excess of positive-charged side chains. Apo B P-2 belongs to the lys- and arg-rich, LDL-receptor domain. Apo E also binds to the agarose-proteoglycan. The results suggest that apo B regions with sequences and charge distributions analogous to those of residues 3359 to 3377, 4230 to 4254, and 2106 and 2121 are among those responsible for the interaction of LDL with intima-media CSPG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3395272     DOI: 10.1161/01.atv.8.4.368

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  27 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

3.  Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.

Authors:  J Borén; K Olin; I Lee; A Chait; T N Wight; T L Innerarity
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

Review 4.  Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.

Authors:  Mohammed M Al Gadban; Mohamed M Alwan; Kent J Smith; Samar M Hammad
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

5.  LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis.

Authors:  John T Melchior; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Roy R Hantgan; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2013-06-26       Impact factor: 5.922

Review 6.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

7.  The renal artery ostium flow diverter: structure and potential role in atherosclerosis.

Authors:  Edward B Neufeld; Zu-Xi Yu; Danielle Springer; Qing Yu; Robert S Balaban
Journal:  Atherosclerosis       Date:  2010-01-28       Impact factor: 5.162

8.  Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix.

Authors:  Edward B Neufeld; Leah M Zadrozny; Darci Phillips; Angel Aponte; Zu-Xi Yu; Robert S Balaban
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

9.  Co-localization of aortic apolipoprotein B and chondroitin sulfate in an injury model of atherosclerosis.

Authors:  Z S Galis; M Z Alavi; S Moore
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress.

Authors:  Jesus A Araujo; Andre E Nel
Journal:  Part Fibre Toxicol       Date:  2009-09-18       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.